Same Indication

Lamotrigine vs Pembrolizumab

Lamotrigine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Lamotrigine and Pembrolizumab.

Mechanism of Action

Lamotrigine: Sodium channel blocker inhibiting glutamate release.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Lamotrigine — 25 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Lamotrigine — C9H7Cl2N5.

Molecular Weight: Lamotrigine — 256.0910 g/mol.

Type: Lamotrigine — Small molecule; Pembrolizumab — Antibody.